BMPR1AP2

Across TCGA pan-cancer cohorts, BMPR1AP2 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of BMPR1AP2’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where BMPR1AP2 RNA is repressed in tumor relative to normal tissue. In most cancer types BMPR1AP2 is over-expressed in tumor, although a few such as BRCA and UCEC show the opposite, repressed pattern.

BRCA, UCEC, and THCA are the cancer types where BMPR1AP2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BMPR1AP2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	−0.183	<.001	6	view →
UCEC	All	All	−0.141	.018	6	view →
THCA	All	All	−0.090	<.001	6	view →
COAD	Female	All	−0.061	.017	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

BMPR1AP2–BRCA

Open the BRCA breakdown →